Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas.
about
Potential for immunotherapy in soft tissue sarcomaRecognition and killing of cancer stem-like cell population in hepatocellular carcinoma cells by cytokine-induced killer cells via NKG2d-ligands recognitionCurrent Immunotherapies for Sarcoma: Clinical Trials and RationaleAutologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer.5T4-specific chimeric antigen receptor modification promotes the immune efficacy of cytokine-induced killer cells against nasopharyngeal carcinoma stem cell-like cells.Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognitionImplication of combined PD-L1/PD-1 blockade with cytokine-induced killer cells as a synergistic immunotherapy for gastrointestinal cancer.Biological Character of RetroNectin Activated Cytokine-Induced Killer Cells.Immunotherapies in sarcoma: Updates and future perspectivesImmunotherapy of cancer stem cells in solid tumors: initial findings and future prospective.Adoptive immunotherapy against sarcomas.Synergy of molecular targeted approaches and immunotherapy in melanoma: preclinical basis and clinical perspectives.Cytokine-induced killer cells as immunotherapy for solid tumors: current evidence and perspectives.Cancer Immunotherapy with Cytokine-Induced Killer Cells.L-Ferritin targets breast cancer stem cells and delivers therapeutic and imaging agents.A comparison between cytokine- and bead-stimulated polyclonal T cells: the superiority of each and their possible complementary role.Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells.Generation and characterization of ErbB2-CAR-engineered cytokine-induced killer cells for the treatment of high-risk soft tissue sarcoma in children.Trial Watch: Adoptive cell transfer for anticancer immunotherapy.Activity of cytokine-induced killer cells against bone and soft tissue sarcoma.CD44v6 as innovative sarcoma target for CAR-redirected CIK cells.Chemotherapy with or without autologous cytokine-induced killer cell transfusion as the first-line treatment for stage IV gastrointestinal cancer: a phase II clinical trial.Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors.Efficiency of Cytokine-Induced Killer Cells in Combination with Chemotherapy for Triple-Negative Breast Cancer.Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapyCytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity
P2860
Q27008830-7C497D86-FBA4-4C29-B61F-9D9552681F65Q27311035-48C0065F-342B-436E-ACEA-C6918D09A519Q28067036-2F22457D-45AB-4F4A-B956-D97A8A4DA156Q33429758-329C631E-12FD-4EE5-8CF0-B4AEEA3ED554Q33884816-B124BE77-4248-4C38-87EB-3D0326CAA877Q36544290-10CB98D9-BC9E-4701-999F-4E9344D4E777Q36962962-483BDA4D-8563-42D7-9B15-F4F44127A8D0Q37084335-16781FA4-5E24-4775-8B71-C2E36FA2E3D3Q37743055-9D5AB951-7C06-4898-B23B-ACE8CE8D2414Q38212354-C03F16A4-082A-4814-A079-557CC0827C40Q38291193-AF3A9E35-EDEC-4BDE-9D0D-0DBBF7D264F1Q38553161-B9787782-F6B5-45C8-BF6D-E232812FF089Q38574526-B149CE57-0F67-4463-8D68-E33D162CCDEAQ38687547-5DA95A49-C416-4AB9-82DB-9600FFAE5CD6Q41784579-FFBDC7A0-8DF3-444D-9E2F-DD735CBD174BQ42079725-2C627E62-2A7A-4E4B-934F-7ADCDBC61776Q42274903-38A0114D-9C84-4F94-8606-3E8C6AAA6F9AQ42371616-255E626A-CC1D-4B25-8C9C-2DB3D156D472Q42702234-D53BDC89-1C62-40A9-B4C8-7C6DDD92951AQ42729198-36B1883B-D7B7-48D8-B5B1-E00DCBFBED6AQ52714322-3A599817-A7C6-4CCB-BF7D-65BA2DCAE02CQ52882119-E3781D0E-2D35-4063-B2A6-E4468F1C6D5DQ54986388-0B6DCDB1-6AE5-4979-B693-6C8A8008FBC6Q55398926-E027DA3F-926A-49C0-9CC0-4D0F4D50D4E4Q58566155-DB0EF01E-7B4E-41A3-82EC-EA6B298885A7Q58694978-7AC364D0-31F5-4287-9869-48749F4948BB
P2860
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas.
@en
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas.
@nl
type
label
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas.
@en
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas.
@nl
prefLabel
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas.
@en
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas.
@nl
P2093
P50
P1433
P1476
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas
@en
P2093
Alberto Pisacane
Andrea Bertotti
Cristina Cammarata
Fabrizio Carnevale-Schianca
Ivana Sarotto
Lorenzo D'Ambrosio
Loretta Gammaitoni
Maja Todorovic
Sara Miano
Wanda Piacibello
P304
P356
10.1158/0008-5472.CAN-13-1559
P407
P50
P577
2013-12-19T00:00:00Z